BAUS guidance webinar

Following the updated BAUS and RCR guidance on how to manage patients during Covid-19, Philip Charlesworth, Surgical Clinical Director and Philip Camilleri, Uro-oncology Clinical Director hosted a webinar to discuss GenesisCare’s response on how this may impact on our private patients wishing to access treatment at during Covid-19. The webinar discusses our intent today, and moving forward as we work through the challenges presented.

Listen here:

Due to time constraints on the webinar we were unable to answer the following question:

Question:
Is there a plan to support 5 fraction SABR prostate treatment at GenesisCare centres other than the MRL in Oxford?

Answer:
Yes. The launch of this service development is currently under review by our Urology Clinical Reference Group to ensure all criteria are met in line with the PACE B protocols including imaging capabilities. A further update on the protocol will follow in the coming weeks. We are currently gauging the interest from Oncologists across of the network in order to prioritise a first wave of centres being mobilised. Feedback so far is mixed and therefore it is expected that not all centres will immediately be able to offer the PACE B protocol. Our aim is to enable the first wave of centres from July 2020.

During the ongoing current changes we’re keen to host similar webinar events on a more regular basis and welcome your feedback to ensure they remain informative and a valuable use of your time. Contact your local team via REM@genesiscare.co.uk to submit your feedback.

Related articles

Celebrating our GenesisCare Game Changers

Bar Code Medication Administration increases patient safety and efficiency

A continued discussion on the #FutureOfSABR – Dr James Good

UK Cancer Patients Receive a Boost with Latest Treatment Technology at Cromwell Hospital in London